Papillary thyroid carcinoma with bone formation

Ki Yong Na, Hyun Sook Kim, Seung Kwan Lee, Woon Won Jung, Ji Youn Sung, Youn Wha Kim, Yong Koo Park

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Bone formation is a rarely encountered finding during histological examination of papillary thyroid carcinoma (PTC). This study aimed to analyze clinicopathological parameters in patients with PTC showing bone formation, to document histological features of bone formation in PTC, and to investigate osteogenic proteins. Bone morphogenic protein (BMP)-9 is known as the most potent osteoinductive protein of the BMP subtypes. Recent research suggests that the activin receptor-like kinase (ALK) 1 is an essential cellular receptor that mediates BMP-9-induced osteogenic signaling. A retrospective review of tumor sections from 567 patients with a diagnosis of PTC was performed. Using immunohistochemistry and quantitative real-time polymerase chain reaction, we investigated the expression of ALK1 and BMP-9 in normal thyroid tissue and PTC samples with and without bone formation. Bone formation was found in 13% of patients with PTC. A significant association was seen between bone formation and old age. BMP-9 expression in tumors was increased compared to that in normal thyroid tissues. BMP-9 expression in tumors with bone formation was not significantly different from that in tumors without bone formation. ALK1 expression in tumors with bone formation was increased compared to that in normal thyroid tissue and tumors without bone formation. Our study suggests that upregulation of ALK1 might be an underlying molecular mechanism that explains osteogenesis in PTC.

Original languageEnglish
Pages (from-to)14-18
Number of pages5
JournalPathology Research and Practice
Volume209
Issue number1
DOIs
Publication statusPublished - 2013 Jan 15

Fingerprint

Osteogenesis
Bone and Bones
Proteins
Neoplasms
Thyroid Gland
Papillary Thyroid cancer
Activin Receptors
Real-Time Polymerase Chain Reaction
Up-Regulation
Immunohistochemistry

Keywords

  • ALK1
  • BMP-9
  • Bone formation
  • Papillary thyroid carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Cell Biology

Cite this

Na, K. Y., Kim, H. S., Lee, S. K., Jung, W. W., Sung, J. Y., Kim, Y. W., & Park, Y. K. (2013). Papillary thyroid carcinoma with bone formation. Pathology Research and Practice, 209(1), 14-18. https://doi.org/10.1016/j.prp.2012.10.001

Papillary thyroid carcinoma with bone formation. / Na, Ki Yong; Kim, Hyun Sook; Lee, Seung Kwan; Jung, Woon Won; Sung, Ji Youn; Kim, Youn Wha; Park, Yong Koo.

In: Pathology Research and Practice, Vol. 209, No. 1, 15.01.2013, p. 14-18.

Research output: Contribution to journalArticle

Na, KY, Kim, HS, Lee, SK, Jung, WW, Sung, JY, Kim, YW & Park, YK 2013, 'Papillary thyroid carcinoma with bone formation', Pathology Research and Practice, vol. 209, no. 1, pp. 14-18. https://doi.org/10.1016/j.prp.2012.10.001
Na, Ki Yong ; Kim, Hyun Sook ; Lee, Seung Kwan ; Jung, Woon Won ; Sung, Ji Youn ; Kim, Youn Wha ; Park, Yong Koo. / Papillary thyroid carcinoma with bone formation. In: Pathology Research and Practice. 2013 ; Vol. 209, No. 1. pp. 14-18.
@article{c75262901b1e42f6bef149ec589cfc54,
title = "Papillary thyroid carcinoma with bone formation",
abstract = "Bone formation is a rarely encountered finding during histological examination of papillary thyroid carcinoma (PTC). This study aimed to analyze clinicopathological parameters in patients with PTC showing bone formation, to document histological features of bone formation in PTC, and to investigate osteogenic proteins. Bone morphogenic protein (BMP)-9 is known as the most potent osteoinductive protein of the BMP subtypes. Recent research suggests that the activin receptor-like kinase (ALK) 1 is an essential cellular receptor that mediates BMP-9-induced osteogenic signaling. A retrospective review of tumor sections from 567 patients with a diagnosis of PTC was performed. Using immunohistochemistry and quantitative real-time polymerase chain reaction, we investigated the expression of ALK1 and BMP-9 in normal thyroid tissue and PTC samples with and without bone formation. Bone formation was found in 13{\%} of patients with PTC. A significant association was seen between bone formation and old age. BMP-9 expression in tumors was increased compared to that in normal thyroid tissues. BMP-9 expression in tumors with bone formation was not significantly different from that in tumors without bone formation. ALK1 expression in tumors with bone formation was increased compared to that in normal thyroid tissue and tumors without bone formation. Our study suggests that upregulation of ALK1 might be an underlying molecular mechanism that explains osteogenesis in PTC.",
keywords = "ALK1, BMP-9, Bone formation, Papillary thyroid carcinoma",
author = "Na, {Ki Yong} and Kim, {Hyun Sook} and Lee, {Seung Kwan} and Jung, {Woon Won} and Sung, {Ji Youn} and Kim, {Youn Wha} and Park, {Yong Koo}",
year = "2013",
month = "1",
day = "15",
doi = "10.1016/j.prp.2012.10.001",
language = "English",
volume = "209",
pages = "14--18",
journal = "Pathology Research and Practice",
issn = "0344-0338",
publisher = "Urban und Fischer Verlag GmbH und Co. KG",
number = "1",

}

TY - JOUR

T1 - Papillary thyroid carcinoma with bone formation

AU - Na, Ki Yong

AU - Kim, Hyun Sook

AU - Lee, Seung Kwan

AU - Jung, Woon Won

AU - Sung, Ji Youn

AU - Kim, Youn Wha

AU - Park, Yong Koo

PY - 2013/1/15

Y1 - 2013/1/15

N2 - Bone formation is a rarely encountered finding during histological examination of papillary thyroid carcinoma (PTC). This study aimed to analyze clinicopathological parameters in patients with PTC showing bone formation, to document histological features of bone formation in PTC, and to investigate osteogenic proteins. Bone morphogenic protein (BMP)-9 is known as the most potent osteoinductive protein of the BMP subtypes. Recent research suggests that the activin receptor-like kinase (ALK) 1 is an essential cellular receptor that mediates BMP-9-induced osteogenic signaling. A retrospective review of tumor sections from 567 patients with a diagnosis of PTC was performed. Using immunohistochemistry and quantitative real-time polymerase chain reaction, we investigated the expression of ALK1 and BMP-9 in normal thyroid tissue and PTC samples with and without bone formation. Bone formation was found in 13% of patients with PTC. A significant association was seen between bone formation and old age. BMP-9 expression in tumors was increased compared to that in normal thyroid tissues. BMP-9 expression in tumors with bone formation was not significantly different from that in tumors without bone formation. ALK1 expression in tumors with bone formation was increased compared to that in normal thyroid tissue and tumors without bone formation. Our study suggests that upregulation of ALK1 might be an underlying molecular mechanism that explains osteogenesis in PTC.

AB - Bone formation is a rarely encountered finding during histological examination of papillary thyroid carcinoma (PTC). This study aimed to analyze clinicopathological parameters in patients with PTC showing bone formation, to document histological features of bone formation in PTC, and to investigate osteogenic proteins. Bone morphogenic protein (BMP)-9 is known as the most potent osteoinductive protein of the BMP subtypes. Recent research suggests that the activin receptor-like kinase (ALK) 1 is an essential cellular receptor that mediates BMP-9-induced osteogenic signaling. A retrospective review of tumor sections from 567 patients with a diagnosis of PTC was performed. Using immunohistochemistry and quantitative real-time polymerase chain reaction, we investigated the expression of ALK1 and BMP-9 in normal thyroid tissue and PTC samples with and without bone formation. Bone formation was found in 13% of patients with PTC. A significant association was seen between bone formation and old age. BMP-9 expression in tumors was increased compared to that in normal thyroid tissues. BMP-9 expression in tumors with bone formation was not significantly different from that in tumors without bone formation. ALK1 expression in tumors with bone formation was increased compared to that in normal thyroid tissue and tumors without bone formation. Our study suggests that upregulation of ALK1 might be an underlying molecular mechanism that explains osteogenesis in PTC.

KW - ALK1

KW - BMP-9

KW - Bone formation

KW - Papillary thyroid carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84872376378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872376378&partnerID=8YFLogxK

U2 - 10.1016/j.prp.2012.10.001

DO - 10.1016/j.prp.2012.10.001

M3 - Article

C2 - 23177617

AN - SCOPUS:84872376378

VL - 209

SP - 14

EP - 18

JO - Pathology Research and Practice

JF - Pathology Research and Practice

SN - 0344-0338

IS - 1

ER -